Oculis Holding AG (OCS) Shareholder's Equity (2021 - 2025)

Oculis Holding AG (OCS) Shareholder's Equity (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shareholder's Equity (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - 7.14 Bn
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 795.79 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 595,226.00
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 1.00 Bn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 14.38 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 19.36 Bn
9 Abivax 90.15 Bn 90.15 Bn - 502.95 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 73.43 Bn
Dec 31, 2024 50.98 Bn
Dec 31, 2023 41.32 Bn
Dec 31, 2022 -101.72 Mn
Dec 31, 2021 -66.11 Mn